|
on the net
This site introduces the Verisyse phakic IOL
November 2004
viewpoint
By: Paul S. Koch, M.D.
For Now, I'll Keep My Phaco Sleeve
November 2004
at press time
Alcon's disappointment with Retaane's trial performance vs. PDT: the IntraLase IPO; plus more
November 2004
the path to paperless - Preparing the Staff for EMR
By: Peter J. Polack, M.D., F.A.C.S.
Major changes require employee "buy-in."
November 2004
rx perspective - New Hyaluronidase Coming Soon
By: Richard A. Lewis, M.D.
Once a key factor in many surgeries, an improved formulation is poised to make an impact.
November 2004
street sense - Stocks Choke on High-Priced Oil
By: Jerry Helzner, Senior Editor
The world is now in the midst of its third oil shock in 30 years. This crisis will be the hardest to overcome.
November 2004
coding & reimbursement - Billing for Refractive Surgery?
By: Suzanne L. Corcoran, C.O.E.
Under certain circumstances, it is possible.
November 2004
spotlight - Faster Recovery and Less Pain with Surface Ablation
By: John Parkinson, M.D.
Moria's Epi-K is jumping into the epi-LASIK marketplace.
November 2004
research digest - Creating a Risk Model for Glaucoma
A group of physicians has proposed a patient-management tool, similar to one used in cardiology.
November 2004
marketplace
Focus on Glaucoma Lasers
November 2004
stat tracker
Laser Vision Correction Outcomes: Surveys Show Chief Complaints and Primary Benefits
November 2004
Bimanual MICS: Advantages Extend Beyond Incision Size
By: William W. Culbertson, M.D.
The technique can facilitate successful completion of difficult cases.
November 2004
FDT and SWAP: Advancing Glaucoma Diagnostics
By: Andrew Rabinowitz, M.D.
Part 3 of our glaucoma management series focuses on the growing role of FDT and SWAP in early detection and diagnosis, how they can be used, and documenting for reimbursement.
November 2004
Equipment Tax Break Set to Expire
By: Raymond Doherty
To take advantage of 50% bonus depreciation, you must act soon.
November 2004
SLT as Primary Treatment
By: Lawrence F. Jindra, M.D.
In this retrospective study, the procedure lowered IOP in glaucoma patients by 35%.
November 2004
Create a Winning Refractive Web Site
By: Robert C. Silkey
Make changes that maximize your site's pulling power.
November 2004
Large Practices Sell Best via Partnership
By: Brad Ruden, M.B.A.
Both the buyer and seller can benefit from this arrangement.
November 2004
Thinking about Retirement?
By: Brad Ruden, M.B.A.
As a solo practitioner, you have two main options for transferring practice ownership. For either, preparations should begin early.
November 2004
IOL Injector UPDATE
By: John Parkinson, M.D.
New inserter systems are easier to use and are fitting through smaller incisions.
November 2004
ASCs vs. Hospitals: Struggling Over a Flawed System
By: Jerry Helzner, Senior Editor
Relations have never been worse. But some see ways to ease the tension.
November 2004
Integrating SLT Into Your Practice
By: Mark A. Latina, M.D.; Monte Dirks, M.D.; Brian A. Francis, M.D.; Ronald L. Gross, M.D.; Robert J. Noecker, M.D., M.B.A.; James B. Wise, M.D.
Learn how this safe, effective procedure can help simplify glaucoma treatment.
November 2004
Controlling Glaucoma With SLT
By: Mark A. Latina, M.D.; Monte Dirks, M.D.; Brian A. Francis, M.D.; Ronald L. Gross, M.D.; Robert J. Noecker, M.D., M.B.A.; James B. Wise, M.D.
Advanced laser technology can help you increase fluid outflow without damaging the trabecular meshwork.
November 2004
Introducing The SLT Option
By: Mark A. Latina, M.D.; Monte Dirks, M.D.; Brian A. Francis, M.D.; Ronald L. Gross, M.D.; Robert J. Noecker, M.D., M.B.A.; James B. Wise, M.D.
A well-planned approach can help you educate your patients about this procedure. Here are some tips from the experts.
November 2004
Putting SLT In Action
By: Mark A. Latina, M.D.; Monte Dirks, M.D.; Brian A. Francis, M.D.; Ronald L. Gross, M.D.; Robert J. Noecker, M.D., M.B.A.; James B. Wise, M.D.
Experts share clinical pearls for successful glaucoma laser therapy.
November 2004
Investing In SLT
By: Mark A. Latina, M.D.; Monte Dirks, M.D.; Brian A. Francis, M.D.; Ronald L. Gross, M.D.; Robert J. Noecker, M.D., M.B.A.; James B. Wise, M.D.
Patient demand and favorable reimbursement guidelines contribute to the appeal of this IOP-lowering therapy.
November 2004
IOL Innovations: Raising the Bar in Cataract Surgery
By: Larry E. Patterson, M.D.; Dan Chambers; Charles Davis, D.O.; Jim Denning, CEO; James C. Loden, M.D.; Rosie Long; Neil F. Martin, M.D.
Find out how these early adopters are faring with crystalens*, the first accommodating IOL.
November 2004
Who Are the "New" Cataract Patients?
By: Larry E. Patterson, M.D.; Dan Chambers; Charles Davis, D.O.; Jim Denning, CEO; James C. Loden, M.D.; Rosie Long; Neil F. Martin, M.D.
Many are baby boomers -- younger and better educated than the previous generation. Here's how to connect with them.
November 2004
Tailor Your Marketing To Your Market
By: Larry E. Patterson, M.D.; Dan Chambers; Charles Davis, D.O.; Jim Denning, CEO; James C. Loden, M.D.; Rosie Long; Neil F. Martin, M.D.
Let people know you're offering a new, technologically advanced IOL. Here's how these practices did it.
November 2004
From Reception to Surgery: A Team Approach
By: Larry E. Patterson, M.D.; Dan Chambers; Charles Davis, D.O.; Jim Denning, CEO; James C. Loden, M.D.; Rosie Long; Neil F. Martin, M.D.
Everyone in the practice plays a role when incorporating this new IOL.
November 2004
Will Lens Implants Overtake LASIK?
By: Larry E. Patterson, M.D.; Dan Chambers; Charles Davis, D.O.; Jim Denning, CEO; James C. Loden, M.D.; Rosie Long; Neil F. Martin, M.D.
This diagnosis gives us a new opportunity to provide good vision.
November 2004
|
